We are collecting your personal data in order to log your interest in attending ESCRS Satellite Meetings. To view our Privacy Policy click here.

Email Address
(this will be your username)
Full Name
Password Confirm Password
Country
EuroTimes Satellite Programme

Thursday 05 September | 13:00 - 14:00

Lunchtime Symposia

Thursday 05 September | 13:00 - 14:00

Location: Amphitheatre Bordeaux

The Great Fluid Debate: Reviewing Treatment Outcome Goals for the Wet AMD Patient

Moderator(s): S. Wolf Switzerland F.G. Holz Germany

S. Wolf Switzerland F.G. Holz Germany
Welcome, opening audience response system questions

F.G. Holz Germany
Review of EURETINA delegate survey data to assess baseline trends

S. Wolf Switzerland
Keys to accurately and consistently diagnosing fluid levels with multi-modal imaging

M. Zinkernagel Switzerland
Debate Side #1: Our goal with AMD patients should be to eliminate all retinal fluid to maximize outcomes

P. Dugel USA
Recent OCT fluid analyses and their clinical implications

R. Tadayoni France
Debate Side #2: AMD patients can tolerate a small amount of SRF with no impact on visual outcome and it may be helpful in some patients

S. Wolf Switzerland F.G. Holz Germany
Panel Discussion: Why is “fluid-free” vs “residual fluid” a difficult outcome decision to make and what future diagnostics and treatments may help both sides of this debate?

Supported by:

Novartis

ZEISS

Thursday 05 September | 13:00 - 14:00

Location: Amphitheatre Havane

Superior Visualization with Swept Source OCT and OCT Angiography

Moderator(s): P. Keane UK

P. Keane UK
Use of Swept Source OCT in challenging cases of central serous chorioretinopathy

C. Hoyng Netherlands
Morphological and topographical appearance of microaneurysms on Swept-Source OCTA

V. Papastefanou UK
Diabetic retinopathy & Swept-Source OCTAngio

A. Gaudric France
Topographic variations of choroidal thickness in healthy eyes on Swept-Source optical coherence tomography

Thursday 05 September | 13:00 - 14:00

Location: Room 241

Photobiomodulation: An Innovative, Mitochondria-targeted Therapy for Dry AMD and Other Ocular Diseases (An Update)

Moderator(s): J. Eells USA M. Munk Switzerland

J. Eells USA
Photobiomodulation for the treatment of retinal and optic nerve disease

K. Valter Australia
From bench to bedside – photobiomodulation in preclinical studies (an update)

M. Munk Switzerland
LIGHTSITE I: clinical analysis of the safety and efficacy of photobiomodulation in subjects with dry age-related macular degeneration

B. Burton UK
LIGHTSITE II: insights from the ongoing multi-center european clinical trial

Thursday 05 September | 13:00 - 14:00

Location: Room 252

ILUVIEN for the Prevention of Relapse in Recurrent Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Moderator(s): B. Bodaghi France Q. Nguyen USA

B. Bodaghi France
Non-infectious uveitis affecting the posterior segment of the eye

M. Cordero Spain
NIU-PS: the unmet patient need

C. Pavesio UK
The 001 study: ILUVIEN for the prevention of relapse in recurrent NIU-PS

R. Khoramnia Germany
ILUVIEN real world data: experience from clinical practice

Q. Nguyen USA
Lessons learned in managing patients with uveitis: avoidance of cumulative damage

Thursday 05 September | 13:00 - 14:00

Location: Amphitheatre Bleu

Transforming DME Clinical Practice

Moderator(s): A. Loewenstein Israel B. Kuppermann USA

F. Behar-Cohen France

Unravelling the inflammation pathway

A. García-Layana Spain

Seeking consensus in DME management: findings from Spain

L. Kodjikian France

Key questions for managing DME in daily practice

H. Selen Kanar Turkey

Switch on, switch off: case series

Panelists:

A. Loewenstein Israel

B. Kuppermann US

F. Behar-Cohen France

A. García-Layana Spain

L. Kodjikian France

H. Selen Kanar Turkey

Discussion and Q&A

Friday 06 September | 9:45 - 10:45

Morning Symposia

Friday 06 September | 9:45 - 10:45

Location: Amphitheatre Bleu

Keeping a Step Ahead of the Disease: Proactive Treatment for nAMD

Moderator(s): L. Kodjikian France

Welcome and introductions
L. Kodjikian France

T&E with Aflibercept: from design to dosing regimen
G. Cheung Singapore

Expanding the evidence: T&E in clinical practice
P. Kaiser USA

Panel discussion: let's discuss: the practicalities of T&E in the clinic
Moderated by: L. Kodjikian France
Panelists: G. Cheung Singapore P. Kaiser USA

Summary and close
L. Kodjikian France

Friday 06 September | 9:45 - 10:45

Location: Salle Maillot

A New Vision in Retinal Gene Therapy: from Clinical Trials to Clinical Practice

Moderator(s): B. Leroy Belgium J-A. Sahel France

J-A. Sahel France
Welcome and introduction

B. Leroy Belgium
Starting with the end in mind: understanding the patient experience

M. Pennesi USA
Setting the scene: developing a retinal gene therapy for RPE65 mutations

B. Leroy Belgium
Patient selection: informing diagnosis through relevant testing

J-A. Sahel France
Retinal gene therapy in clinical practice: perspectives from an expert center

B. Leroy Belgium J-A. Sahel France
Q&A

B. Leroy Belgium
Closing remarks

Friday 06 September | 9:45 - 10:45

Location: Room 251

Seeing the Invisible - Transparent Subthreshold Treatment with Navigated Microsecond Pulsing Laser

Moderator(s): G. Staurenghi Italy

C. Orduna Spain
Experiences from 1 year navigated microsecond pulsing laser treatments in DME

N-A. Striebe Germany
Navigated microsecond pulsing treatment for central serous chorioretinopathy. A 100 cases review.

E. Di Carlo Germany
Short term efficacy and safety of navigated microsecond pulsing laser treatment in patients affected by macular edema after BRVO

J. Chhablani USA
Feasibility and study results of navigated microsecond pulsing peripheral laser treatment in diabetic retinopathy

Friday 06 September | 13:00 - 14:00

Lunchtime Symposia

Friday 06 September | 13:00 - 14:00

Location: Salle Maillot

Ranibizumab — Retinal Care For all Ages: RIVAL (nAMD) to RAINBOW (ROP)

Moderator(s): R. Tadayoni France

R. Tadayoni France
Welcome

P. Schlottmann Argentina
Clinical value of treat & extend regimen and the RIVAL study

A. Koh Singapore
Changing clinical paradigm in diabetic retinopathy

N. Eter Germany
A new horizon in ROP: the RAINBOW study

Panel Discussion

R. Tadayoni France


Summary and close

Friday 06 September | 13:00 - 14:00

Location: Amphitheatre Bleu

Emerging Evidence: Molecular Properties and Patient Outcomes

Moderator(s): F. Behar-Cohen France

Welcome and introductions
F. Behar-Cohen France

Design, binding, downstream effect
P. Kaiser USA

Could insights into drug dynamics inform patient management?
C.X.Y Qian Canada

Consider this: should a stable retina drive the T&E regimen?
V. Chaudhary Canada

Panel Discussion: Let’s discuss: how does the evidence inform a proactive approach in clinical practice?
Moderated by: P. Kaiser USA
Panelists: C.X.Y. Qian Canada V. Chaudhary Canada

Summary of key learnings
F. Behar-Cohen France

Friday 06 September | 13:00 - 14:00

Location: Room 252

Breaking the Cycle of Recurrence in DME: Where Research Meets Clinical Practice

Moderator(s): L. Kodjikian France

A. Augustin Germany
Inflammatory response and cytokines in DME

P. Udaondo Spain
Prognostic and predictive biomarkers: research meets clinical practice

F. Bandello Italy
Switch reality: preventing recurrence, preserving vision

Friday 06 September | 13:00 - 14:00

Location: Amphitheatre Havane

Take Another Look: Uncovering New Advances and Future Applications of Ultra-widefield

Moderator(s): T. Peto UK

S. Sadda USA
Variability of the normal peripheral choroidal circulation

P. Stanga UK
International classification and guidelines for widefield imaging

T. Peto UK
Deep learning and artificial intelligence for diagnosing retinal disease

Friday 06 September | 13:00 - 14:00

Location: Room 342

Illuminating the Role of Angiopoietins in Retinal Diseases

Moderator(s): J-F. Korobelnik France

H. Augustin Germany
Spotlight on the angiopoietin pathway

J. Monés Spain
Clinical evidence for the role of Ang-2 in retinal diseases

Friday 06 September | 13:00 - 14:00

Location: Room 351

New Mirante Multimodal Imaging and OCT-A Analytics Can Help Breakthrough Tricky Cases of Retinal Disorders

Moderator(s): G. Staurenghi Italy

G. Staurenghi Italy
The importance of multimodal imaging: the new NIDEK Mirante SLO/OCT platform

T. Ach Germany
SD-OCT and OCT-A scans: which, when, and why? Some practical aspects

S. Sadda USA
Retro mode imaging in AMD and macular dystrophies

Friday 06 September | 13:00 - 14:00

Location: Room 241

Reimagine your Retina Surgery with Bausch + Lomb

Moderator(s): Y. Le Mer France

R. Carvalho Portugal
The power of Stellaris Elite™ - taking performance further

E. Bali Belgium
Key learnings and surgical pearls with Vitesse™

Bausch + Lomb R&D team
How we’re raising the bar in retina innovation

Saturday 07 September | 9:45 - 10:45

Morning Symposia

Saturday 07 September | 9:45 - 10:45

Location: Room 252

The Vitreoretinal Procedure - Integration, Stability, Speed

Moderator(s): R. Tadayoni France

R. Tadayoni France
Introduction and opening remarks

K. Al Sabti Kuwait
Go beyond 3D visualization

F. Devin France
Complex and VR surgical cases using the advanced features of the Constellation® Vision System

S. Rizzo Italy
Speed, flow, stability, access-the new HyperVit™ 20K vitrectomy Probe

M. Mura Saudi Arabia
27+® as go-to technology for challenging vitreoretinal cases

J.A. Pournaras Switzerland
Modern surgical management of vitreoretinal pathologies

N. Bechrakis Germany
Management of intraocular tumors with an advanced surgical system

Saturday 07 September | 9:45 - 10:45

Location: Amphitheatre Bleu

Unsurpassed Vision Gains and Optimized Patient Outcomes in DME

Moderator(s): J-F Korobelnik France

Welcome and introductions
J-F. Korobelnik France

Pathogenesis of retinal vascular diseases
A. Ambresin Switzerland

Optimizing patient management with early, intensive treatment
S. Sivaprasad UK

Aflibercept in the real world: emerging data in DME
J-F Korobelnik France

Panel discussion: review of current recommendations and summary of key learnings
Moderated by: J-F Korobelnik France

Panelists: A. Ambresin Switzerland

S. Sivaprasad UK

Saturday 07 September | 9:45 - 10:45

Location: Amphitheatre Bordeaux

nAMD Management: Beyond the Horizon

Moderator(s): F. Bandello Italy M. de Smet Switzerland

M. De Smet Switzerland

Welcome and introduction

F. Bandello Italy

Unmet needs in the management of nAMD

L. Kodjikian France

What we have learnt about nAMD in the last 15 years

M. Stumpp Switzerland

DARPin® proteins, a new approach

A. García-Layana Spain

What's in the pipeline for patients?

Saturday 07 September | 9:45 - 10:45

Location: Salle Maillot

Applying Advanced Digital Technology in Practice

Moderator(s): N. Bressler USA

N. Bressler USA

Chair’s introduction: advanced use of digital technology – examining the potential positive and negative impact on medical practice

A. Loewenstein Israel

Public health need for home monitoring in diabetic retinopathy and age-related macular degeneration

P. Keane UK

Application of deep learning systems for diabetic retinopathy and AMD in clinical practice

N. Bressler USA

The future of clinical trials and clinical practice

Saturday 07 September | 9:45 - 10:45

Location: Room 351

Complement C3 Inhibition in Geographic Atrophy

Moderator(s): F.G. Holz Germany

J. Monés Spain

The role of complement in geographic atrophy

U. Chakravaraty UK

Results from the FILLY phase 2 trial

I. Pearse UK

Evaluation of baseline characteristics on GA lesion progression in the FILLY trial

F.G. Holz Germany

Derby and Oaks phase 3 trials in GA

Saturday 07 September | 13:00 - 14:00

Lunchtime Symposia

Saturday 07 September | 13:00 - 14:00

Location: Amphitheatre Bordeaux

New Horizons in nAMD Treatment

Moderator(s): F.G. Holz Germany

F.G. Holz Germany

Welcome and introduction

P. Kaiser USA

Challenges and opportunities in nAMD care

A. Koh Singapore

Moderated panel discussion

R. Hamilton UK

New horizons in nAMD: updates from advanced clinical program

F.G. Holz Germany

Moderated panel discussion

F.G. Holz Germany

Summary and close

Saturday 07 September | 13:00 - 14:00

Location: Room 252

Ready for Prime Time: Clinical Evidence of Advances in 27G Surgery

Moderator(s): P. Stalmans Belgium

P. Stalmans Belgium

First evidence for clinical trial of 27G vs 23G surgery

E. El Rayes Egypt

How innovation is making 27G a reality

C. Mazit France

Management of retinal detachment using 27g and a prospective randomised study comparing 25G vs 27G for the management of ERM and macular holes

F. Nerinckx Belgium

First experience with a new shorter 27G vitrectomy kit

Saturday 07 September | 13:00 - 14:00

Location: Room 351

Innovative Thinking in Retinal Disease

Moderator(s): J. Seddon USA

A. García-Layana Spain

A. Minnella Italy

How to manage patients at risk of AMD with STARS questionnaire

A. Tufail UK

Artificial intelligence. Where do we go from here?

C. Creuzot-Garcher France

Diabetic retinopathy and OCT-A

D. Crabb UK

And what do people with AMD see?

Saturday 07 September | 13:00 - 14:00

Location: Room 241

Management of Retinal Diseases with SubLiminal Laser Therapy

Moderator(s): V. Chong UK

V. Chong UK

How retina lasers are different from each other?

A. Filloy Spain

Fovea-involving DME: reasons for the SubLiminal approach

L. Altay Germany

SubLiminal laser in CCSC management

L. Wu Costa Rica

Why SubLiminal laser should be favored vs PDT for CCSC treatment

V. Chong UK

New treatment perspectives and conclusion

Saturday 07 September | 13:00 - 14:00

Location: Room 342

Delivering the Future of nAMD Management

Moderator(s): R. Tadayoni France

A. Loewenstein Israel

Outcomes in real-world settings and therapeutic advancements

P. Campochiaro USA

Continuous delivery: A future approach to nAMD management

Saturday 07 September | 13:00 - 14:00

Location: Salle Maillot

Retinal Imaging Advancements

Moderator(s): J-F. Korobelnik France

J-F. Korobelnik France

Exploring new boundaries of OCT-A

G. Staurenghi Italy

Next generation of ultra-widefield angiography

G. Lang Germany

Integrated diagnostic imaging maximizing your diagnostic instruments